Carilex MedicalROCO:7726 -0.31%34 Market Cap is NT$648.7 Mil as of Jul. 06, 2026. GuruFocus rates ROCO:7726 with a GF Score™ of 34/100. The stock has 5 warning signs investors should review. Among 868 Medical Devices & Instruments companies, Carilex Medical ranks worse than 76.5% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Carilex Medical's share price for the quarter that ended in Dec. 2025 was NT$41. Carilex Medical's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 20.3 Mil. Therefore, Carilex Medical's market cap for the quarter that ended in Dec. 2025 was NT$832.5 Mil.
Carilex Medical's quarterly market cap
declined
from Dec. 2024 (NT$906.6 Mil) to Jun. 2025 (NT$842.6 Mil) and
declined
from Jun. 2025 (NT$842.6 Mil) to Dec. 2025 (NT$832.5 Mil).
Carilex Medical's annual market cap
increased
from Dec. 2023 (NT$0.0 Mil) to Dec. 2024 (NT$906.6 Mil) but then
declined
from Dec. 2024 (NT$906.6 Mil) to Dec. 2025 (NT$832.5 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Carilex Medical's Enterprise Value for Today is NT$596.6 Mil.
Carilex Medical (ROCO:7726) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Carilex Medical Market Cap Related Terms
Carilex Medical Market Cap Historical Data
* Premium members only.
The historical data trend for Carilex Medical's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Carilex Medical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carilex Medical Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Carilex Medical's Market Cap distribution charts can be found below:
* The bar in red indicates where Carilex Medical's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Carilex Medical's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carilex Medical (ROCO:7726) has a Market Cap of NT$648.7 Mil as of Jul. 06, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Carilex Medical and its competitors. According to the industry distribution chart, Carilex Medical ranks #664 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 76.5%.
Is Carilex Medical's Market Cap too high?
Carilex Medical's current Market Cap is NT$648.7 Mil. Based on the distribution chart, Carilex Medical ranks #664 out of 868 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Carilex Medical has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Carilex Medical's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Carilex Medical ranks #664 out of 868 companies for Market Cap. This places Carilex Medical in the lower half of its industry. The industry median Market Cap is 120.17. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 120.17, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Carilex Medical and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 120.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carilex Medical's current Market Cap is NT$648.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carilex Medical stock overvalued right now?
Carilex Medical (ROCO:7726) has a current Market Cap of NT$648.7 Mil. The current Market Cap is NT$648.7 Mil. Carilex Medical's overall GF Score™ is 34/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Carilex Medical (ROCO:7726), the current Market Cap is NT$648.7 Mil as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Carilex Medical Inc is a company engaged in the wound care industry by developing leading-edge technology in the prevention and treatment of wounds. Their expertise is in research and development, manufacturing, and quality control and assurance allow us to provide unparalleled products in wound care management in the form of comprehensive product lines proven to prevent and manage pressure sores and wounds. They offer products in the form of Support Surfaces, Chair Cushion and Negative Pressure Wound Therapy.
34GF Score
Get the complete analysis for ROCO:7726
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7726 has been successfully added to your 
